Literature DB >> 11533147

Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old.

G S Lynch1, R T Hinkle, J S Chamberlain, S V Brooks, J A Faulkner.   

Abstract

1. Differences in the effect of age on structure-function relationships of limb muscles of mdx (dystrophin null) and control mice have not been resolved. We tested the hypotheses that, compared with limb muscles from age-matched control mice, limb muscles of 6- to 17-month-old mdx mice are larger but weaker, with lower normalised force and power, whereas those from 24- to 28-month-old mdx mice are smaller and weaker. 2. The maximum isometric tetanic force (P(o)) and power output of limb muscles from 6-, 17-, 24- and 28-month-old mdx and control mice were measured in vitro at 25 degrees C and normalised with respect to cross-sectional area and muscle mass, respectively. 3. Body mass at 6 and 28 months was not significantly different in mdx and control mice, but that of control mice increased 16 % by 17 months and then declined 32 % by 28 months. The body masses of mdx mice declined linearly with age with a decrease of 25 % by 28 months. From 6 to 28 months of age, the range in the decline in the masses of EDL and soleus muscles of mdx and control mice was from 16 to 28 %. The muscle masses of mdx mice ranged from 9 % to 42 % greater than those of control mice at each of the four ages and, even at 28 months, the masses of EDL and soleus muscles of mdx mice were 17 % and 22 % greater than control values. 4. For mdx mice of all ages, muscle hypertrophy was highly effective in the maintenance of control values for absolute force for both EDL and soleus muscles and for absolute power of soleus muscles. Throughout their lifespan, muscles of mdx mice displayed significant weakness with values for specific P(o) and normalised power approximately 20 % lower than values for control mice at each age. For muscles of both strains, normalised force and power decreased approximately 28 % with age, and consequently weakness was more severe in muscles of old mdx than in those of old control mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533147      PMCID: PMC2278782          DOI: 10.1111/j.1469-7793.2001.00591.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  43 in total

1.  Contraction-induced injury: recovery of skeletal muscles in young and old mice.

Authors:  S V Brooks; J A Faulkner
Journal:  Am J Physiol       Date:  1990-03

2.  Skeletal muscle regeneration after crush injury in dystrophic mdx mice: an autoradiographic study.

Authors:  M D Grounds; J K McGeachie
Journal:  Muscle Nerve       Date:  1992-05       Impact factor: 3.217

3.  Myosin molecular motor dysfunction in dystrophic mouse diaphragm.

Authors:  C Coirault; F Lambert; S Marchand-Adam; P Attal; D Chemla; Y Lecarpentier
Journal:  Am J Physiol       Date:  1999-12

4.  Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles.

Authors:  J W Carnwath; D M Shotton
Journal:  J Neurol Sci       Date:  1987-08       Impact factor: 3.181

5.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

6.  Functional significance of compensatory overloaded rat fast muscle.

Authors:  R R Roy; I D Meadows; K M Baldwin; V R Edgerton
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-02

7.  Time course study of the isometric contractile properties of mdx mouse striated muscles.

Authors:  C Pastoret; A Sebille
Journal:  J Muscle Res Cell Motil       Date:  1993-08       Impact factor: 2.698

8.  Muscle development in mdx mutant mice.

Authors:  J Dangain; G Vrbova
Journal:  Muscle Nerve       Date:  1984 Nov-Dec       Impact factor: 3.217

9.  The mdx mouse skeletal muscle myopathy: II. Contractile properties.

Authors:  G R Coulton; N A Curtin; J E Morgan; T A Partridge
Journal:  Neuropathol Appl Neurobiol       Date:  1988 Jul-Aug       Impact factor: 8.090

10.  Twitch and tetanus in mdx mouse muscle.

Authors:  J G Quinlan; S R Johnson; M K McKee; S P Lyden
Journal:  Muscle Nerve       Date:  1992-07       Impact factor: 3.217

View more
  123 in total

1.  Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.

Authors:  Paul Gregorevic; David R Plant; Kerri S Leeding; Leon A Bach; Gordon S Lynch
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Posttetanic potentiation in mdx muscle.

Authors:  Ian Curtis Smith; Jian Huang; Joe Quadrilatero; Allan Russell Tupling; Rene Vandenboom
Journal:  J Muscle Res Cell Motil       Date:  2010-10-23       Impact factor: 2.698

3.  Excitation-contraction coupling and sarcoplasmic reticulum function in mechanically skinned fibres from fast skeletal muscles of aged mice.

Authors:  David R Plant; Gordon S Lynch
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

4.  Ventilation during air breathing and in response to hypercapnia in 5 and 16 month-old mdx and C57 mice.

Authors:  Jerome Gayraud; Stefan Matecki; Karim Hnia; Dominique Mornet; Christian Prefaut; Jacques Mercier; Alain Michel; Michele Ramonatxo
Journal:  J Muscle Res Cell Motil       Date:  2007-04-13       Impact factor: 2.698

5.  Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice.

Authors:  Nicole Stupka; David R Plant; Jonathan D Schertzer; Tennent M Emerson; Rhonda Bassel-Duby; Eric N Olson; Gordon S Lynch
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

6.  Age-related changes in the mechanical properties of the epimysium in skeletal muscles of rats.

Authors:  Yingxin Gao; Tatiana Y Kostrominova; John A Faulkner; Alan S Wineman
Journal:  J Biomech       Date:  2007-11-26       Impact factor: 2.712

Review 7.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

8.  Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling.

Authors:  Richard M Lovering; Luke Michaelson; Christopher W Ward
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-15       Impact factor: 4.249

9.  Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.

Authors:  Kitipong Uaesoontrachoon; James L Quinn; Kathleen S Tatem; Jack H Van Der Meulen; Qing Yu; Aditi Phadke; Brittany K Miller; Heather Gordish-Dressman; Ennio Ongini; Daniela Miglietta; Kanneboyina Nagaraju
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

10.  Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model.

Authors:  May Christine V Malicdan; Satoru Noguchi; Yukiko K Hayashi; Ikuya Nonaka; Ichizo Nishino
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.